Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Anhui Anke Biotechnology (Group) (300009 CH)
Watchlist
16
Analysis
Health Care
•
China
Anhui Anke Biotechnology (Group) Company Ltd. develops, manufactures and markets pharmaceuticals and health-care products including genetic and cellular engineering research and products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Thematic (Sector/Industry)
•
04 Aug 2016 16:05
China's Disconnect on Illegal Drugs
Senior Chinese officials regularly make all the appropriate noises about the evils of illicit drug use in China, but they seem unable to do...
Bixmoor
Follow
622 Views
Share
bullish
•
Thematic (Sector/Industry)
•
26 Feb 2016 05:38
Coming to the HKEX Soon....................
Bloomberg has published a story (that others have cited) that WuXi Pharmatech has picked bankers for an HK listing of its biologics manufacturing...
Kemp Dolliver, CFA
225 Views
Share
bullish
•
Thematic (Sector/Industry)
•
18 Feb 2016 23:01
Time to Go Shopping for Healthcare
The decline in equity markets has created opportunities to buy a variety of healthcare stocks at attractive valuations. Insider purchases have...
Kemp Dolliver, CFA
250 Views
Share
bullish
•
Thematic (Sector/Industry)
•
09 Jul 2015 06:01
Who's Optimistic About Pharmacy's Future in China? China Nepstar's Controlling Shareholder
China Nepstar's Chairman and his China Neptunus Drugstore Holding Ltd. (54% owner) has offered $2.60/ADS to take the company private (announcement...
Kemp Dolliver, CFA
375 Views
Share
bearish
•
Thematic (Sector/Industry)
•
01 Jul 2015 22:01
China ADR Privatizations: The Challenges of Getting the Best Deal
The stellar performance of China’s stock markets over the past twelve months (Shanghai +121%, Shenzhen +161%, and Hong Kong +17%) has led to a...
Kemp Dolliver, CFA
430 Views
Share
First
Previous
1
2
3
4
Next
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x